--

Dr Alan Makepeace initially trained as a chemical engineer obtaining a first class honours degree from Imperial College, London University. He subsequently commenced medical training, qualifying in 1977 from King's College Hospital. His initial postgraduate training was in surgery, becoming a fellow of the Royal College of Surgeons of England and a fellow of the Royal College of Surgeons of Edinburgh in 1981 and undertook post fellowship training in plastic surgery.

Dr. Makepeace entered into clinical oncology in 1982, doing his time as a registrar and senior registrar on the Middlesex/Mount Vernon rotation and has acted as locum to the Windeyer. He was the professorial chair of Radiation Oncology at the Middlesex Hospital prior to being appointed his current consultant post at Mount Vernon Hospital.

Dr. Makepeace is responsible for the breast service for the Mount Vernon Cancer Network providing the service to the South Bucks NHS Trust (Wycombe General Hospital). He was the National Director of Continuing Professional Development for the Royal College of Radiologists as well-being a member of their Training and Accreditation Committee.

Dr Makepeace is a senior oncologist based at the Mount Vernon Cancer Centre and has specialised in the treatment of breast cancer for over 20 years. He has led the development of the chemotherapy service for breast cancer at BMI The Chiltern Hospital which is staffed by three specialist chemotherapy nurses. For patients receiving treatment at the Chiltern, oncology advice is available on a 24-hour basis; making treatment easily accesible for patients whenever they need it. This service was recently further enhanced by a new, purpose-built chemotherapy suite which was opened in October 2009 by Princess Alexandra.

In addition, for those patients requiring radiotherapy treatment, this may be arranged under Dr Makepeace's care at Mount Vernon Cancer Centre. Dr Makepeace also works closely with colleagues from the Oxford Cancer Centre with whom he liaises should it be more convenient for patients to receive their radiotherapy in that unit.

• Radiotherapy
• Chemotherapy
• Hormonal Treatment
• Biological Agents

• Breast Oncology